Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $3.02B.
ENTERPRISE VALUE (EV)
$3.02B
Arcutis Biotherapeutics, Inc.
Market Cap
$3.05B
Enterprise Value (EV)
$3.02B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | $3.05B | $3.02B |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.04B | $3.00B |
| Denali Therapeutics Inc. (DNLI)vs › | $3.04B | $2.86B |
| Enliven Therapeutics, Inc. (ELVN)vs › | $2.97B | $2.83B |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.84B | $2.18B |
| TransMedics Group, Inc. (TMDX)vs › | $2.81B | $3.21B |
| AtriCure, Inc. (ATRC)vs › | $2.79B | $2.69B |
| CareDx, Inc (CDNA)vs › | $3.40B | $3.04B |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | $5.09B |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.41B | $3.10B |
Market Cap
$3.05B
Total Debt
$6.27M
Cash
$42.91M
Enterprise Value
$3.02B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
